Goldenwell Biotech Valuation
| GWLL Stock | USD 1.95 0.06 2.99% |
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Goldenwell Biotech regular Real Value cannot be determined due to lack of data. The prevalent price of Goldenwell Biotech is $1.95. Our model calculates the value of Goldenwell Biotech from evaluating the firm fundamentals such as Shares Outstanding of 96 M, return on equity of -36.4, and Return On Asset of -17.19 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Goldenwell Biotech's price fluctuation is out of control at this time. Calculation of the real value of Goldenwell Biotech is based on 3 months time horizon. Increasing Goldenwell Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Goldenwell pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Goldenwell Biotech. Since Goldenwell Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Goldenwell Pink Sheet. However, Goldenwell Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.95 | Real 0.0 | Hype 0.0 | Naive 2.52 |
The intrinsic value of Goldenwell Biotech's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Goldenwell Biotech's stock price.
Estimating the potential upside or downside of Goldenwell Biotech helps investors to forecast how Goldenwell pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Goldenwell Biotech more accurately as focusing exclusively on Goldenwell Biotech's fundamentals will not take into account other important factors: About Goldenwell Biotech Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Goldenwell Biotech. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Goldenwell Biotech based exclusively on its fundamental and basic technical indicators. By analyzing Goldenwell Biotech's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Goldenwell Biotech's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Goldenwell Biotech. We calculate exposure to Goldenwell Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Goldenwell Biotech's related companies.Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. The company was incorporated in 2019 and is based in Twinsburg, Ohio. Goldenwell Biotech is traded on OTC Exchange in the United States.
8 Steps to conduct Goldenwell Biotech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Goldenwell Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Goldenwell Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Goldenwell Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Goldenwell Biotech's revenue streams: Identify Goldenwell Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Goldenwell Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Goldenwell Biotech's growth potential: Evaluate Goldenwell Biotech's management, business model, and growth potential.
- Determine Goldenwell Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Goldenwell Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Goldenwell Biotech Growth Indicators
Investing in growth stocks can be very risky. If the company such as Goldenwell Biotech does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Revenue Growth | 235.70% | |
| Float Shares | 36M |
Other Information on Investing in Goldenwell Pink Sheet
Goldenwell Biotech financial ratios help investors to determine whether Goldenwell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goldenwell with respect to the benefits of owning Goldenwell Biotech security.